Azelis Delivers 11% Free Cash Flow Growth in H1 2025
Azelis (Brussels:AZE):
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250730152197/en/
Highlights H1 2025
- Revenue of EUR 2.2bn in H1 2025, representing year-on-year increase of 0.6% (+3.3% on a constant currency basis), with 1.2% organic revenue growth and 2.2% revenue growth contribution from acquisitions offsetting the negative F/X impact during the period.
- Gross profit of EUR 515m resulting in gross profit margin of 23.9%. The 68 bp gross margin contraction reflects the mix effect from higher growth contribution from Industrial Chemicals and the Group's less mature businesses.
- Adjusted EBITA of EUR 234m results in adjusted EBITA margin of 10.9%, and conversion margin of 45.5%. The EBITA and conversion margins do not yet reflect the full benefit of cost savings measures announced at the beginning of Q2.
- Net profit of EUR 85m represents a decline of 14.6% over the prior year, driven by the lower operating profit.
- Free cash flow increased by 10.8% over the prior year to EUR 151m despite the lower EBITDA. Cash conversion expanded by more than 10 percentage points to 63.8% underscoring the resilient, cash-generative nature of the business model.
- Two acquisitions were completed in H1 2025, and a third was announced shortly after the close of the period. The three companies had combined annual revenue of over EUR 100m in 2024.
- The Group is focused on managing its costs whilst uncertainty persists in the near-term, whilst continuing to execute on its medium-term strategy to capture the benefits of an attractive industry.
Comment from Anna Bertona, Group CEO: "Our results in H1 2025 reflect the resilience of our business model and the dedication of our teams, allowing us to navigate short-term volatility whilst continuing to position Azelis as the industry reference in our focus end markets.
Despite the impact of the growing trade and geopolitical uncertainty around the world, we remain confident that we have the right strategy to ensure that we capture the opportunities created by the volatility in the industry and emerge stronger than before.”
View source version on businesswire.com: https://www.businesswire.com/news/home/20250730152197/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rimini Street Announces Fiscal Second Quarter 2025 Financial and Operating Results31.7.2025 22:01:00 CEST | Press release
Second Quarter Financial Highlights Include: Gross margin of 60.4% compared to 59.1% in the prior year Adjusted Calculated Billings of $107.9 million compared to $103.8 million in the prior year Adjusted EBITDA of $13.0 million compared to $8.8 million in the prior year Revenue Retention Rate of 90% compared to 88% in the prior year Rimini Street, Inc., (the “Company”) (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the fiscal second quarter ended June 30, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731791846/en/ Rimini Street Announces Fiscal Second Quarter 2025 Financial and Operating Results Select Second Quarter 2025 Financial Results Revenue was $104.1 million for the 2025 second quarter, an increase of 1.0% compared to $103.1 million for the same
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development31.7.2025 20:56:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation (“VoxCell”), a leader in 3D bioprinting and human-like tissue modeling, are pleased to announce a strategic collaboration aimed at enhancing preclinical research and accelerating the path from discovery to clinical trials. This partnership combines Altasciences’ comprehensive early-phase drug development capabilities with VoxCell’s cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment. By integrating VoxCell’s high-resolution 3D bioprinted tissue platforms into Altasciences’ discovery and preclinical services, both companies aim to reduce R&D timelines and increase the success rate of investigational therapies. “We’re proud to partner with VoxCell BioInnovation to bring next-generation tissue modeling into the early stages of drug development,” said Steve Mason, Co-Chief Operating Officer at Altasciences. “This collaboration aligns with
GEA Raises Forecast for Fiscal Year 2025 and Provides Positive Outlook31.7.2025 19:40:00 CEST | Press release
Due to a very positive operating performance in the first 6 months and expectations for the remainder of the financial year 2025, GEA Group Aktiengesellschaft is raising all guidance parameters based on preliminary figures as follows: Organic sales growth 2 to 4 percent (previously 1 to 4 percent), EBITDA-margin before restructuring expenses 16.2 to 16.4 percent (previously 15.6 to 16.0 percent) and ROCE 34 to 38 percent (previously 30 to 35 percent). The company will publish its complete statement for the 2nd quarter (half-year financial report) on August 7, 2025. “Our positive development continues. The additional improvements are broad-based, supported by a favorable order situation as well as margin improvements and efficiency gains across the Group. Once again, we are thus demonstrating our strength in executing on our plans,” said GEA CEO Stefan Klebert. Alongside improving the profitability indicators EBITDA margin before restructuring expenses and ROCE, GEA also increased order
Global Technology Leaders Adopt Access Advance's Video Distribution Patent Pool31.7.2025 18:58:00 CEST | Press release
A diverse group of global companies across the video ecosystem has joined Access Advance's Video Distribution Patent ("VDP") Pool and is now sharing why they selected this pool. Positioned as a balanced, transparent, and comprehensive video codec licensing solution for the video streaming industry, the pool brings together major patent holders, video platform operators, and stakeholders in the consumer device market in an effort to help the industry navigate the complex licensing challenges in the rapidly evolving video distribution markets. The VDP Pool has attracted an unprecedented list of industry leaders as both licensors and licensees, including ByteDance, Dolby, JVC Kenwood, Kuaishou, HFI (an affiliate of MediaTek), Mitsubishi, OPPO, Philips, Tencent, and other major technology companies. This broad participation spans the entire video ecosystem, from content platforms serving billions of users to semiconductor companies powering video devices worldwide. Collaborative Framework
Interactive Brokers Launches Version 1.0 of IBKR Desktop, Delivering a Comprehensive Trading Experience in One Platform31.7.2025 16:00:00 CEST | Press release
New platform combines market intelligence, product discovery, and execution tools in a modern, scalable interface Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, today announced the official launch of Version 1.0 of IBKR Desktop, a next-generation trading platform that balances simplicity with advanced functionality. This release follows two years of iterative beta development and introduces a fully featured desktop trading experience for investors worldwide. IBKR Desktop is designed to serve as a primary trading platform for both retail and professional clients. It combines all key trading workflow components, including discovery, analysis, execution, and portfolio management, in a powerful and intuitive interface. “We built IBKR Desktop to meet the needs of all investors, from experienced traders to those just getting started,” said Milan Galik, Chief Executive Officer of Interactive Brokers. “With this release, we are delivering a platform that is easy to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom